{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:20:19Z","timestamp":1789518019229,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Established determinants of health in the elderly help guide routines for indicated vaccine administration, while unmeasured frailty may limit vaccine access. We evaluate the performance of the 2024-2025 COVID-19 vaccine adapted to the Omicron JN.1 lineage in a Swedish population aged \u226565 years (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u2009245 696). Vaccine effectiveness (VE) on COVID-19-related hospitalization and a negative control outcome (NCO; all-cause mortality) are assessed in various cohorts between October 1, 2024 to March 31, 2025. The VE was 75% (95% CI 70%\u201379%) overall, and 84% (95% CI 80%\u201387%) and 65% (95% CI 34%\u201382%) in individuals with and without vaccination with the prior updated COVID-19 vaccine in 2023-2024, respectively. The NCO in individuals exposed to the study vaccine in 2024-2025 was half of that seen in those not exposed to the vaccine (HR 0.43 [95% CI 0.40\u20130.45]). Removing individuals hospitalized with COVID-19 from this population did not change the difference in NCO (HR 0.43 [95% CI 0.41-0.46]). These findings suggest the presence of selection effects arising from under-provision of health services to elderly individuals with frailty. The healthy vaccinee effect should be considered in observational studies of the effectiveness of updated COVID-19 vaccines in elderly populations.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-76312-x","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T17:04:10Z","timestamp":1786208650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Healthy vaccinee effect in the evaluation of updated COVID-19 vaccines in elderly populations"],"prefix":"10.1038","volume":"17","author":[{"given":"Johan","family":"Lyth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Spreco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-5609","authenticated-orcid":false,"given":"Jorma","family":"Hinkula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8370-2950","authenticated-orcid":false,"given":"Olle","family":"Bj\u00f6rneld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5306-2753","authenticated-orcid":false,"given":"Olle","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Nordvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3955-0443","authenticated-orcid":false,"given":"\u00d6rjan","family":"Dahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin A.","family":"Gursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6049-5402","authenticated-orcid":false,"given":"Toomas","family":"Timpka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"76312_CR1","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1056\/NEJMsb2506929","volume":"392","author":"V Prasad","year":"2025","unstructured":"Prasad, V. & Makary, M. A. An evidence-based approach to covid-19 vaccination. N. Engl. J. Med. 392, 2484\u20132486 (2025).","journal-title":"N. Engl. J. Med."},{"key":"76312_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15585\/mmwr.mm7337e2","volume":"73","author":"LMD Panagiotakopoulos","year":"2024","unstructured":"Panagiotakopoulos, L. M. D. et al. Use of COVID-19 Vaccines for Persons Aged \u22656 Months: Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2024\u20132025. MMWR Morb. Mortal. Wkly Rep. 73, 19\u2013824 (2024).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"76312_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59344-7","volume":"16","author":"HJ Appaneal","year":"2025","unstructured":"Appaneal, H. J. et al. Early effectiveness of the BNT162b2 KP.2 vaccine against COVID-19 in the US Veterans Affairs Healthcare System. Nat. Commun. 16, 4033 (2025).","journal-title":"Nat. Commun."},{"key":"76312_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.15585\/mmwr.mm7406a1","volume":"74","author":"RCS Link-Gelles","year":"2025","unstructured":"Link-Gelles, R. C. S. et al. Interim Estimates of 2024\u20132025 COVID-19 vaccine effectiveness among adults aged \u226518 years \u2014 vision and ivy networks, September 2024\u2013January 2025. MMWR Morb. Mortal. Wkly Rep. 74, 73\u201382 (2025).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"76312_CR5","first-page":"00380","volume":"S1473-3099","author":"CH Hansen","year":"2025","unstructured":"Hansen, C. H., Lassauni\u00e8re, R., Rasmussen, M., Moustsen-Helms, I. R. & Valentiner-Branth, P. Effectiveness of the BNT162b2 and mRNA-1273 JN.1-adapted vaccines against COVID-19-associated hospitalisation and death: a Danish, nationwide, register-based, cohort study. Lancet Infect. Dis. S1473-3099, 00380\u201300389 (2025).","journal-title":"Lancet Infect. Dis."},{"key":"76312_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1154-y","volume":"15","author":"C Remschmidt","year":"2015","unstructured":"Remschmidt, C., Wichmann, O. & Harder, T. Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review. BMC Infect. Dis. 15, 429 (2015).","journal-title":"BMC Infect. Dis."},{"key":"76312_CR7","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1017\/S0950268824000098","volume":"152","author":"TB H\u00f8eg","year":"2024","unstructured":"H\u00f8eg, T. B., Haslam, A. & Prasad, V. The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm-benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds. Epidemiol. Infect. 152, e51 (2024).","journal-title":"Epidemiol. Infect."},{"key":"76312_CR8","first-page":"374","volume":"47","author":"F Berrino","year":"2023","unstructured":"Berrino, F., Donzelli, A., Bellavite, P. & Malatesta, G. COVID-19 vaccination and all-cause and non-COVID-19 mortality. A revaluation of a study carried out in an Italian Province. Epidemiol. Prev. 47, 374\u2013378 (2023). English.","journal-title":"Epidemiol. Prev."},{"key":"76312_CR9","doi-asserted-by":"publisher","first-page":"106976","DOI":"10.1016\/j.ijid.2024.02.019","volume":"142","author":"T F\u00fcrst","year":"2024","unstructured":"F\u00fcrst, T., Bazalov\u00e1, A., Fry\u010d\u00e1k, T. & Jano\u0161ek, J. Does the healthy vaccinee bias rule them all? Association of COVID-19 vaccination status and all-cause mortality from an analysis of data from 2.2 million individual health records. Int J. Infect. Dis. 142, 106976 (2024).","journal-title":"Int J. Infect. Dis."},{"key":"76312_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-23619-x","volume":"25","author":"O Vencalek","year":"2025","unstructured":"Vencalek, O., Furst, T., Princova, E. & Furstova, J. The Mirror of Erised: a retrospective population-wide study of Czech all-cause mortality data by COVID-19 vaccination status. BMC Public Health 25, 2427 (2025).","journal-title":"BMC Public Health"},{"key":"76312_CR11","doi-asserted-by":"publisher","first-page":"e103690","DOI":"10.7554\/eLife.103690","volume":"14","author":"H Chemaitelly","year":"2025","unstructured":"Chemaitelly, H. et al. Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in Qatar. eLife 14, e103690 (2025).","journal-title":"eLife"},{"key":"76312_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jclinepi.2008.06.014","volume":"62","author":"JC Nelson","year":"2009","unstructured":"Nelson, J. C., Jackson, M. L., Weiss, N. S. & Jackson, L. A. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J. Clin. Epidemiol. 62, 687\u2013694 (2009).","journal-title":"J. Clin. Epidemiol."},{"key":"76312_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ije\/dyi274","volume":"35","author":"LA Jackson","year":"2006","unstructured":"Jackson, L. A., Jackson, M. L., Nelson, J. C., Neuzil, K. M. & Weiss, N. S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J. Epidemiol. 35, 337\u2013344 (2006).","journal-title":"Int J. Epidemiol."},{"key":"76312_CR14","unstructured":"Public Health Agency of Sweden. Recommendations for COVID-19 vaccination from September 1, 2025. Accessed August 2, 2026. https:\/\/www.folkhalsomyndigheten.se\/nyheter-och-press\/nyhetsarkiv\/2024\/oktober\/dags-for-vaccination-mot-influensa-och-covid-19\/"},{"key":"76312_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","volume":"21","author":"M Lipsitch","year":"2010","unstructured":"Lipsitch, M., Tchetgen Tchetgen, E. & Cohen, T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology 21, 383\u2013388 (2010).","journal-title":"Epidemiology"},{"key":"76312_CR16","doi-asserted-by":"publisher","first-page":"106598","DOI":"10.1016\/j.jinf.2025.106598","volume":"91","author":"G Ahimbisibwe","year":"2025","unstructured":"Ahimbisibwe, G. et al. Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses. J. Infect. 91, 106598 (2025).","journal-title":"J. Infect."},{"key":"76312_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/vaccines13080799","volume":"13","author":"H Taskov","year":"2025","unstructured":"Taskov, H. & Shivarov, V. Humoral and Memory B Cell Responses Following SARS-CoV-2 Infection and mRNA Vaccination. Vaccines (Basel) 13, 799 (2025).","journal-title":"Vaccines (Basel)"},{"key":"76312_CR18","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried, L. P. et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med Sci. 56, M146\u2013M156 (2001).","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"76312_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ije\/dyi275","volume":"35","author":"LA Jackson","year":"2006","unstructured":"Jackson, L. A. et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J. Epidemiol. 35, 345\u2013352 (2006).","journal-title":"Int J. Epidemiol."},{"key":"76312_CR20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/NEJMra2301292","volume":"391","author":"DH Kim","year":"2024","unstructured":"Kim, D. H. & Rockwood, K. Frailty in Older Adults. N. Engl. J. Med. 391, 538\u2013548 (2024).","journal-title":"N. Engl. J. Med."},{"key":"76312_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.puhe.2023.06.007","volume":"221","author":"A Spreco","year":"2023","unstructured":"Spreco, A., Andersson, C., Sj\u00f6dahl, R. & Timpka, T. Concordance between COVID-19 mortality statistics derived from clinical audit and death certificates in \u00d6sterg\u00f6tland county, Sweden. Public Health 221, 46\u201349 (2023).","journal-title":"Public Health"},{"key":"76312_CR22","doi-asserted-by":"publisher","first-page":"e17941","DOI":"10.1371\/journal.pone.0017941","volume":"6","author":"T Timpka","year":"2011","unstructured":"Timpka, T. et al. Requirements and design of the prosper protocol for implementation of information infrastructures supporting pandemic response: a nominal group study. PLoS ONE 6, e17941 (2011).","journal-title":"PLoS ONE"},{"key":"76312_CR23","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.2196\/jmir.7101","volume":"19","author":"A Spreco","year":"2017","unstructured":"Spreco, A., Eriksson, O., Dahlstr\u00f6m, \u00d6, Cowling, B. J. & Timpka, T. Integrated detection and prediction of influenza activity for real-time surveillance: algorithm design. J. Med Internet Res. 19, e211 (2017).","journal-title":"J. Med Internet Res."},{"key":"76312_CR24","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3201\/eid2410.171940","volume":"24","author":"A Spreco","year":"2018","unstructured":"Spreco, A., Eriksson, O., Dahlstr\u00f6m, \u00d6, Cowling, B. J. & Timpka, T. Evaluation of nowcasting for detecting and predicting local influenza epidemics, Sweden, 2009-2014. Emerg. Infect. Dis. 24, 1868\u20131873 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"76312_CR25","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.3201\/eid2611.200448","volume":"26","author":"A Spreco","year":"2020","unstructured":"Spreco, A. et al. Nowcasting (Short-Term Forecasting) of influenza epidemics in local settings, Sweden, 2008-2019. Emerg. Infect. Dis. 26, 2669\u20132677 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"76312_CR26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3201\/eid2803.210267","volume":"28","author":"A Spreco","year":"2022","unstructured":"Spreco, A. et al. Nowcasting (Short-Term Forecasting) of COVID-19 hospitalizations using syndromic healthcare data, Sweden, 2020. Emerg. Infect. Dis. 28, 564\u2013571 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"76312_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan, H. et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol. 173, 676\u2013682 (2011).","journal-title":"Am. J. Epidemiol."},{"key":"76312_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele, T. J.; Ding, P. Sensitivity analysis in observational research: introducing the E-Value. Ann. Intern. Med. 167, 268\u2013274 (2017).","journal-title":"Ann. Intern. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76312-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76312-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76312-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T17:14:12Z","timestamp":1786209252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76312-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76312"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76312-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8014"}}